Abstract
Background: Limited data exist on adherence to fecal calprotectin (FCP) testing in patients with inflammatory bowel disease. Methods: Completion rates for patients who had at least one FCP test ordered (n = 3082) and a subgroup with C-reactive protein, complete blood count, and Clostridium difficile tests also ordered (n = 1563) were analyzed. Results: More patients completed blood than stool tests, with FCP having the poorest adherence of all tests analyzed. Older patients had higher FCP completion rates. No differences were noted in completion rates across age, gender, or ethnicity for blood tests. Conclusions: Further studies are needed to develop strategies that improve the uptake of FCP.
Original language | English |
---|---|
Article number | otab028 |
Journal | Crohn's and Colitis 360 |
Volume | 3 |
Issue number | 3 |
DOIs | |
State | Published - 1 Jul 2021 |
Externally published | Yes |
Keywords
- Biomarkers
- Calprotectin
- Crohn's disease
- Inflammatory bowel disease
- Ulcerative colitis